908 DEVICES INC (MASS) Stock News
NASDAQ:MASS - Nasdaq - US65443P1021 - Common Stock - Currency: USD
MASS Latest News, Press Relases and Analysis
908 Devices Appoints Christopher D. Brown to its Board of Directors
Metropolitan Washington Council of Governments Adds 908 Devices’ XplorIR to Its Hazardous Materials Response Toolkit
Why 908 Devices Stock Rocketed More Than 18% Higher This Week
New Strong Buy Stocks for April 1st
AFRM, TKOMY, FOLD, MASS and VFC have been added to the Zacks Rank #1 (Strong Buy) List on April 1, 2025.
Why 908 Devices Stock Rocketed More Than 18% Higher This Week
The Romanian Customs Authority has deployed 27 MX908 detection devices. Before market open on Wednesday, 908 Devices announced -- no doubt happily -- that the Romanian Customs Authority has deployed 27 of the company's MX908 devices throughout its organization. Its deal was done through a program headed by the European Union, of which Romania is a member country.
Romanian Customs Authority Adopts 908 Devices’ MX908 for Border Security Operations
All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy
908 Devices (MASS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference
Is Johnson & Johnson (JNJ) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing […]
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
908 Devices (MASS) delivered earnings and revenue surprises of 18.52% and 2.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: LUCD
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
Warby Parker Inc. (WRBY): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential
We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Warby Parker Inc. (NYSE:WRBY) stands against Nicholas J. Pritzker’s other stock picks with huge upside potential. Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, […]
908 Devices Inc. (MASS): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential
We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where 908 Devices Inc. (NASDAQ:MASS) stands against Nicholas J. Pritzker’s other stock picks with huge upside potential. Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, […]
Tesla, Inc. (TSLA): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential
We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Tesla, Inc. (NASDAQ:TSLA) stands against Nicholas J. Pritzker’s other stock picks with huge upside potential. Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, a […]
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of 51.92% and 3.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: INGN
Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know
Lucid Diagnostics (LUCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: LUCD
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CVRX
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 36.84% and 2.04%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: AVNS
MTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise
Mettler-Toledo International's Q1 results reflect growth in the Laboratory business, a decline in Industrial, and continued weakness in the Food Retail segment.
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
Why Nutex Health Inc. (NUTX) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Nutex Health Inc. (NASDAQ:NUTX) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
Why 908 Devices Inc. (MASS) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where 908 Devices Inc. (NASDAQ:MASS) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
Why Palvella Therapeutics, Inc. (PVLA) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Palvella Therapeutics, Inc. (NASDAQ:PVLA) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
Why GRAIL, Inc. (GRAL) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where GRAIL, Inc. (NASDAQ:GRAL) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a comeback […]
Why agilon health, inc. (AGL) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where agilon health, inc. (NYSE:AGL) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Monopar Therapeutics Inc. (NASDAQ:MNPR) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
Why Journey Medical Corporation (DERM) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Journey Medical Corporation (NASDAQ:DERM) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a […]
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, & Contango are well-poised to gain.
